Related Documents
-
Notice: Human drugs:
Patent extension; regulatory review period determinations— Premarket approval application manufacturing information and operations; review and inspection
107 reads -
E7-19349
78 reads -
Notice: Meetings: Procedures for handling post-approval studies imposed by premarket approval application order
69 reads -
Notice: Food for human consumption:
Food labeling— Drug Safety and Risk Management Advisory Committee
38 reads -
Notice: Meetings: International Conference on Harmonisation; S8 immunotoxicity studies for human pharmaceuticals
88 reads -
Notice: Reports and guidance documents; availability, etc.: Pharmacogenomic data submissions; industry guidance
39 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— EMTRIVA
24 reads -
Notice: Reports and guidance documents; availability, etc.: Prominent and conspicuous mark of manufacturers on single-use devices; compliance with Medical Device User Fee and Modernization Act of 2002, as amended
27 reads -
Notice: Meetings: Hepatitis A virus serological assays; industry guidance
97 reads -
Notice: Committees; establishment, renewal, termination, etc.: Medical devices; radiology devices, bone sonometers; Class II special controls
47 reads -
Notice: Food for human consumption:
Food labeling— Existing label stock use after trans fat labeling effective date of January 1, 2006; extension request; addendum
116 reads -
Notice: Meetings: Genetic toxicology study results integration; recommended approaches
76 reads -
Notice: Reports and guidance documents; availability, etc.: FDA advisory committee meetings; open public hearing
23 reads -
Notice: Meetings: Application user fees for combination products
77 reads -
Notice: Medical devices: Class II Special Controls Guidance Document: Instrumentation for Clinical Multiplex Test Systems
140 reads -
Notice: Reports and guidance documents; availability, etc.: Tinnitus masker devices; class II special controls guidance
77 reads -
Notice: Meetings: Intervertebral body fusion device; Class II special controls
48 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— TYSABRI
143 reads -
Notice: Meetings: Medical Devices Advisory Committee
97 reads -
Notice: Reports and guidance documents; availability, etc.: FDA Advisory Committees; members and staff procedures for determining conflict of interest and eligibility for participation; draft guidance
22 reads
Related Documents
Flag this document
2 Pages
